csv. check, some, votes

Objection pursuant to Rule 112: Extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole (D061354)

Reference: B9-0103/2019

Date: 10.10.2019

Filter by Country

Overall Result

Total: 751 MEPs

402 For

222 Against

39 Abstention

88 Did not vote

402 For

222 Against

39 Abstention

88 Did not vote

Kira Marie PETER-HANSEN

Country: Denmark

Group: Greens/European Free Alliance (Greens/EFA)

Debate contributions: 11

My vote:

For

European People's Party (EPP)

Against: 130

Did not vote: 23

Click for details

Progressive Alliance of Socialists and Democrats (S&D)

Did not vote: 14

Click for details

Renew Europe (Renew)

Did not vote: 11

Click for details

Greens/European Free Alliance (Greens/EFA)

Did not vote: 6

Click for details

Identity and Democracy (ID)

Did not vote: 10

Click for details

European Conservatives and Reformists (ECR)

Did not vote: 13

Click for details

Non-attached Members (NI)

Did not vote: 9

Click for details

The Left in the European Parliament (GUE/NGL)

Did not vote: 2

Click for details

←